Senior AI/ML Engineer \xe2\x80\x93 Sequence Learning
At GSK we see a world in which advanced applications of artificial intelligence and machine learning (AI/ML) will allow us to develop novel therapies to existing diseases and to quickly respond to emerging or changing diseases with personalized drugs, driving better outcomes at reduced cost with fewer side effects. It is an ambitious vision that will require the development of products and solutions at the cutting edge of AI/ML. If that excites you, we\'d love to chat.
The AI/ML Sequence Learning Team applies machine learning and AI methods to biological sequence (DNA, RNA, protein) data from large-scale human genetic, functional genomic and single cell experiments. Models operating directly on sequence data that can infer how variants alter protein/RNA abundance, structure and function have the potential to be transformative in drug discovery, empowering us to find new life saving medicines.
We are looking for a Senior AI/ML Engineer to help us make this vision a reality. Competitive candidates will have a track record in developing state-of-the-art (SOTA) deep learning models for solving challenging real world scientific problems. You should be an outstanding scientist with in-depth knowledge in modern machine learning. You can convert vaguely described biological/drug discovery challenges into well-defined machine learning problems. You can independently execute and deliver full AI/ML driven solutions from sourcing training data, design and implementing SOTA machine learning models, testing, benchmarking and product driven research for model performance improvement, to shipping stable, tested, performant code and services in an agile environment.
The AI/ML team is built on the principles of ownership, accountability, continuous development, and collaboration. We hire for the long term, and we\'re motivated to make this a great place to work. Our leaders will be committed to your career and development from day one.
We\xe2\x80\x99re combining the power of genetic and genomic insights into what causes disease, with the speed and scale of AI/ML to make better predictions about who a treatment might work for, and why. We believe this powerful combination of data and technology holds the key to fundamentally transforming medical discovery for the better, improving R&D success rates and shaping how even the most challenging diseases, like neurological conditions and cancer, can be both prevented and treated.
In 2021 we delivered four major product approvals: Cabenuva for HIV, Jemperli for endometrial cancer, Xevudy for COVID-19 and Apretude, our new long-acting medicine for HIV prevention.
In this role you will
MNCJobs.co.uk will not be responsible for any payment made to a third-party. All Terms of Use are applicable.